Behavioural Intervention
Computerized Decision Support for High Cholesterol
Recruiting1 award1 criteria
Boston, Massachusetts
This trial aims to see if using a computer alert can help doctors identify patients with a genetic high cholesterol condition called Familial Hypercholesterolemia. The main focus is to find out if the
Base-editing Technology
VERVE-102 for High Cholesterol
Recruiting1 awardPhase 1
Chicoutimi
"This trial is testing a new medication called VERVE-102 on patients with high cholesterol or heart disease. The medication uses a technology that targets a specific gene in the liver to lower cholesterol levels. The
Popular Filters
Trials for Hypercholesterolemia Patients
PCSK9 Inhibitor
Oral PCSK9 Inhibitor for High Cholesterol
Recruiting1 awardPhase 3
Port Orange, Florida
This trial is testing a new medication called MK-0616 to see if it can lower bad cholesterol levels in adults with a genetic condition that causes very high cholesterol. These patients often need special treatments because regular medications may not work well for them. The study will measure how much MK-0616 can reduce bad cholesterol over several months.
Behavioral Intervention
Cascade Screening for High Cholesterol
Recruiting1 award3 criteria
Philadelphia, Pennsylvania
This trial will test 2 approaches to help families of those with Familial Hypercholesterolemia (FH) get tested and treated. It will compare the effectiveness of the approaches to usual care. The goal is to promote screening and health equity.
Trials for High Cholesterol Patients
PCSK9 Inhibitor
Oral PCSK9 Inhibitor for High Cholesterol
Recruiting1 awardPhase 3
Port Orange, Florida
This trial is testing a new medication called MK-0616 to see if it can lower bad cholesterol levels in adults with a genetic condition that causes very high cholesterol. These patients often need special treatments because regular medications may not work well for them. The study will measure how much MK-0616 can reduce bad cholesterol over several months.
Behavioral Intervention
Cascade Screening for High Cholesterol
Recruiting1 award3 criteria
Philadelphia, Pennsylvania
This trial will test 2 approaches to help families of those with Familial Hypercholesterolemia (FH) get tested and treated. It will compare the effectiveness of the approaches to usual care. The goal is to promote screening and health equity.
Behavioral Intervention
Comprehensive Care Approach for High Cholesterol
Recruiting1 award1 criteria
Multiple Locations, Pennsylvania
This trialwill use implementation science to improve diagnosis and treatment of high cholesterol, to prevent heart attacks in people with familial hypercholesterolemia. It could help other health care systems improve diagnosis rates.
Behavioral Intervention
Motivational Interviewing for High Cholesterol
Recruiting2 awardsPhase 3
Duluth, Minnesota
This trial aims to help patients with suspected Familial Hypercholesterolemia (FH) by using motivational interviews. These interviews educate patients about their health risks and encourage them to inform their family members. The goal is to improve disease management and early detection in relatives.
Phase 3 Trials
PCSK9 Inhibitor
Oral PCSK9 Inhibitor for High Cholesterol
Recruiting1 awardPhase 3
Port Orange, Florida
This trial is testing a new medication called MK-0616 to see if it can lower bad cholesterol levels in adults with a genetic condition that causes very high cholesterol. These patients often need special treatments because regular medications may not work well for them. The study will measure how much MK-0616 can reduce bad cholesterol over several months.
Behavioral Intervention
Motivational Interviewing for High Cholesterol
Recruiting2 awardsPhase 3
Duluth, Minnesota
This trial aims to help patients with suspected Familial Hypercholesterolemia (FH) by using motivational interviews. These interviews educate patients about their health risks and encourage them to inform their family members. The goal is to improve disease management and early detection in relatives.
Anti-sense Oligonucleotide
Inclisiran for Hypercholesterolemia
Recruiting1 awardPhase 3
Boca Raton, Florida
This trial will test the safety, side effects, and effectiveness of a medication called inclisiran in children between the ages of 6 and 12 with a specific type of high cholesterol called heterozy
Anti-sense oligonucleotide
Inclisiran for Hypercholesterolemia
Recruiting1 awardPhase 3
San Francisco, California
This trial will test the safety, side effects, and effectiveness of a drug called inclisiran in children aged 2 to under 12 years who have a genetic condition that causes high cholesterol levels.
Trials With No Placebo
Behavioral Intervention
Cascade Screening for High Cholesterol
Recruiting1 award3 criteria
Philadelphia, Pennsylvania
This trial will test 2 approaches to help families of those with Familial Hypercholesterolemia (FH) get tested and treated. It will compare the effectiveness of the approaches to usual care. The goal is to promote screening and health equity.
Behavioral Intervention
Comprehensive Care Approach for High Cholesterol
Recruiting1 award1 criteria
Multiple Locations, Pennsylvania
This trialwill use implementation science to improve diagnosis and treatment of high cholesterol, to prevent heart attacks in people with familial hypercholesterolemia. It could help other health care systems improve diagnosis rates.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.